Antimicrobial Resistance Patterns, Sequence Types, Virulence and Carbapenemase Genes of Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates from a Tertiary Care Teaching Hospital in Zunyi, China

References

• Wyres KL, Lam MMC, Holt KE. Population genomics of Klebsiella pneumoniae. Nat Rev Microbiol. 2020;18(6):344–359. doi:10.1038/s41579-019-0315-1
   PubMed Web of Science ®Google Scholar
• Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):18. doi:10.1186/s12941-017-0191-3
   PubMed Web of Science ®Google Scholar
• Wang G, Zhao G, Chao X, Xie L, Wang H. The Characteristic of Virulence, Biofilm and Antibiotic Resistance of Klebsiella pneumoniae. Int J Environ Res Public Health. 2020;17(17). doi:10.3390/ijerph17176278
   Web of Science ®Google Scholar
• Zhang R, Chan EW, Zhou H, Chen S. Prevalence and genetic characteristics of carbapenem-resistant Enterobacteriaceae strains in China. Lancet Infect Dis. 2017;17(3):256–257. doi:10.1016/S1473-3099(17)30072-5
   PubMed Web of Science ®Google Scholar
• Zhang D, Hu S, Sun J, et al. Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017. J Infect Public Health. 2019;12(2):195–199. doi:10.1016/j.jiph.2018.10.003
   PubMed Web of Science ®Google Scholar
• Tao G, Tan H, Ma J, Chen Q. Resistance Phenotype and Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Isolated from Nanjing Children’s Hospital in Jiangsu Province, China. Infect Drug Resist. 2022;15:5435–5447. doi:10.2147/IDR.S377068
   PubMed Web of Science ®Google Scholar
• Vamsi SK, Moorthy RS, Hemiliamma MN, Chandra Reddy RB, Chanderakant DJ, Sirikonda S. Phenotypic and genotypic detection of carbapenemase production among gram negative bacteria isolated from hospital acquired infections. Saudi Med J. 2022;43(3):236–243. doi:10.15537/smj.2022.43.3.20210809
   PubMed Web of Science ®Google Scholar
• Li J, Huang Z, Tang M, et al. Clonal Dissemination of Multiple Carbapenemase Genes in Carbapenem-Resistant Enterobacterales Mediated by Multiple Plasmids in China. Infect Drug Resist. 2021;14:3287–3295. doi:10.2147/IDR.S327273
   PubMed Web of Science ®Google Scholar
• Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11(4):589–603. doi:10.1128/CMR.11.4.589
   PubMed Web of Science ®Google Scholar
• Cerceo E, Deitelzweig SB, Sherman BM, Amin AN. Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: overview, Implications for Clinical Practice, and Emerging Treatment Options. Microb Drug Resist. 2016;22(5):412–431. doi:10.1089/mdr.2015.0220
   PubMed Web of Science ®Google Scholar
• Algammal AM, Ibrahim RA, Alfifi KJ, et al. A First Report of Molecular Typing, Virulence Traits, and Phenotypic and Genotypic Resistance Patterns of Newly Emerging XDR and MDR Aeromonas veronii in Mugil seheli. Pathogens. 2022;11(11):1262. doi:10.3390/pathogens11111262
   PubMed Web of Science ®Google Scholar
• Algammal AM, Hashem HR, Al-Otaibi AS, et al. Emerging MDR-Mycobacterium avium subsp. avium in house-reared domestic birds as the first report in Egypt. BMC Microbiol. 2021;21(1):237. doi:10.1186/s12866-021-02287-y
   PubMed Web of Science ®Google Scholar
• Algammal AM, Abo Hashem ME, Alfifi KJ, et al. Sequence Analysis, Antibiogram Profile, Virulence and Antibiotic Resistance Genes of XDR and MDR Gallibacterium anatis Isolated from Layer Chickens in Egypt. Infect Drug Resist. 2022;15:4321–4334. doi:10.2147/IDR.S377797
   PubMed Web of Science ®Google Scholar
• Makharita RR, El-Kholy I, Hetta HF, et al. Antibiogram and Genetic Characterization of Carbapenem-Resistant Gram-Negative Pathogens Incriminated in Healthcare-Associated Infections. Infect Drug Resist. 2020;13:3991–4002. doi:10.2147/IDR.S276975
   PubMed Web of Science ®Google Scholar
• Kareem SM, Al-Kadmy IMS, Kazaal SS, et al. Detection of gyrA and parC Mutations and Prevalence of Plasmid-Mediated Quinolone Resistance Genes in Klebsiella pneumoniae. Infect Drug Resist. 2021;14:555–563. doi:10.2147/IDR.S275852
   PubMed Web of Science ®Google Scholar
• Vargas JM, Moreno Mochi MP, Nunez JM, et al. Virulence factors and clinical patterns of multiple-clone hypermucoviscous KPC-2 producing K. pneumoniae. Heliyon. 2019;5(6):e01829. doi:10.1016/j.heliyon.2019.e01829
   PubMed Web of Science ®Google Scholar
• Aljanaby A. Role of rmpA, wabG, uge, Ycfm, fimh1, EntB, Ybt-irp2 and kfu genes in pathogenicity of Klebsiella pneumoniae: an overview. Int J Chemtech Res. 2017;10:391.
   Google Scholar
• Struve C, Roe CC, Stegger M, et al. Mapping the Evolution of Hypervirulent Klebsiella pneumoniae. mBio. 2015;6(4):e00630. doi:10.1128/mBio.00630-15
   PubMed Web of Science ®Google Scholar
• Fang CT, Chuang YP, Shun CT, Chang SC, Wang JT. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med. 2004;199(5):697–705. doi:10.1084/jem.20030857
   PubMed Web of Science ®Google Scholar
• Struve C, Bojer M, Krogfelt KA. Identification of a conserved chromosomal region encoding Klebsiella pneumoniae type 1 and type 3 fimbriae and assessment of the role of fimbriae in pathogenicity. Infect Immun. 2009;77(11):5016–5024. doi:10.1128/IAI.00585-09
   PubMed Web of Science ®Google Scholar
• Cortes G, Borrell N, de Astorza B, Gomez C, Sauleda J, Alberti S. Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect Immun. 2002;70(5):2583–2590. doi:10.1128/IAI.70.5.2583-2590.2002
   PubMed Web of Science ®Google Scholar
• Bachman MA, Oyler JE, Burns SH, et al. Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect Immun. 2011;79(8):3309–3316. doi:10.1128/IAI.05114-11
   PubMed Web of Science ®Google Scholar
• Shi Q, Lan P, Huang D, et al. Diversity of virulence level phenotype of hypervirulent Klebsiella pneumoniae from different sequence type lineage. BMC Microbiol. 2018;18(1):94. doi:10.1186/s12866-018-1236-2
   PubMedGoogle Scholar
• Yang K, Liu S, Li H, et al. NDM-1-Positive K. pneumoniae at a Teaching Hospital in Southwestern China: clinical Characteristics, Antimicrobial Resistance, Molecular Characterization, Biofilm Assay, and Virulence. Can J Infect Dis Med Microbiol. 2020;2020:9091360. doi:10.1155/2020/9091360
   PubMed Web of Science ®Google Scholar
• Jin Z, Wang Z, Gong L, et al. Molecular epidemiological characteristics of carbapenem-resistant Klebsiella pneumoniae among children in China. AMB Express. 2022;12(1):89. doi:10.1186/s13568-022-01437-3
   PubMed Web of Science ®Google Scholar
• Le T, Wang L, Zeng C, Fu L, Liu Z, Hu J. Clinical and microbiological characteristics of nosocomial, healthcare-associated, and community-acquired Klebsiella pneumoniae infections in Guangzhou, China. Antimicrob Resist Infect Control. 2021;10(1):41. doi:10.1186/s13756-021-00910-1
   PubMed Web of Science ®Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing: 31th Informational Supplement. Clinical and Laboratory Standards Institute (CLSI); 2021.
   Google Scholar
• Yao B, Xiao X, Wang F, Zhou L, Zhang X, Zhang J. Clinical and molecular characteristics of multi-clone carbapenem-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in a tertiary hospital in Beijing, China. Int J Infect Dis. 2015;37:107–112. doi:10.1016/j.ijid.2015.06.023
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Candan ED, Aksoz N. Klebsiella pneumoniae: characteristics of carbapenem resistance and virulence factors. Acta Biochim Pol. 2015;62(4):867–874. doi:10.18388/abp.2015_1148
   PubMed Web of Science ®Google Scholar
• Tsai YM, Wang S, Chiu HC, Kao CY, Wen LL. Combination of modified carbapenem inactivation method (mCIM) and EDTA-CIM (eCIM) for phenotypic detection of carbapenemase-producing Enterobacteriaceae. BMC Microbiol. 2020;20(1):315. doi:10.1186/s12866-020-02010-3
   PubMed Web of Science ®Google Scholar
• Remya PA, Shanthi M, Sekar U. Characterisation of virulence genes associated with pathogenicity in Klebsiella pneumoniae. Indian J Med Microbiol. 2019;37(2):210–218. doi:10.4103/ijmm.IJMM_19_157
   PubMed Web of Science ®Google Scholar
• Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005;43(8):4178–4182. doi:10.1128/JCM.43.8.4178-4182.2005
   PubMed Web of Science ®Google Scholar
• Hu Y, Liu C, Shen Z, et al. Prevalence, risk factors and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in patients from Zhejiang, China, 2008-2018. Emerg Microbes Infect. 2020;9(1):1771–1779. doi:10.1080/22221751.2020.1799721
   PubMed Web of Science ®Google Scholar
• Lan P, Jiang Y, Zhou J, Yu Y. A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae. J Glob Antimicrob Resist. 2021;25:26–34. doi:10.1016/j.jgar.2021.02.020
   PubMed Web of Science ®Google Scholar
• Haji SH, Aka STH, Ali FA. Prevalence and characterisation of carbapenemase encoding genes in multidrug-resistant Gram-negative bacilli. PLoS One. 2021;16(11):e0259005. doi:10.1371/journal.pone.0259005
   PubMed Web of Science ®Google Scholar
• Nordmann P, Poirel L. Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria. Clin Infect Dis. 2019;69(Suppl 7):S521–S528. doi:10.1093/cid/ciz824
   PubMed Web of Science ®Google Scholar
• van Duin D, Bonomo RA. Ceftazidime/Avibactam and Ceftolozane/Tazobactam: second-generation beta-Lactam/beta-Lactamase Inhibitor Combinations. Clin Infect Dis. 2016;63(2):234–241. doi:10.1093/cid/ciw243
   PubMed Web of Science ®Google Scholar
• Shirley M. Ceftazidime-Avibactam: a Review in the Treatment of Serious Gram-Negative Bacterial Infections. Drugs. 2018;78(6):675–692. doi:10.1007/s40265-018-0902-x
   PubMed Web of Science ®Google Scholar
• Zhang P, Shi Q, Hu H, et al. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China. Clin Microbiol Infect. 2020;26(1):e121–e124. doi:10.1016/j.cmi.2019.08.020
   Web of Science ®Google Scholar
• Soriano A, Carmeli Y, Omrani AS, Moore LSP, Tawadrous M, Irani P. Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: a Systematic Literature Review. Infect Dis Ther. 2021;10(4):1989–2034. doi:10.1007/s40121-021-00507-6
   PubMed Web of Science ®Google Scholar
• Chen D, Li H, Zhao Y, et al. Characterization of carbapenem-resistant Klebsiella pneumoniae in a tertiary hospital in Fuzhou, China. J Appl Microbiol. 2020;129(5):1220–1226. doi:10.1111/jam.14700
   PubMed Web of Science ®Google Scholar
• Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785–796. doi:10.1016/S1473-3099(13)70190-7
   PubMed Web of Science ®Google Scholar
• Logan LK, Weinstein RA. The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: the Impact and Evolution of a Global Menace. J Infect Dis. 2017;215(suppl_1):S28–S36. doi:10.1093/infdis/jiw282
   PubMed Web of Science ®Google Scholar
• Yu F, Wang S, Lv J, et al. Coexistence of OXA-48-Producing Klebsiella pneumoniae and Escherichia coli in a Hospitalized Patient Who Returned from Europe to China. Antimicrob Agents Chemother. 2017;61(4). doi:10.1128/AAC.02580-16
   Web of Science ®Google Scholar
• Han R, Shi Q, Wu S, et al. Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China. Front Cell Infect Microbiol. 2020;10:314. doi:10.3389/fcimb.2020.00314
   PubMed Web of Science ®Google Scholar
• Liao W, Liu Y, Zhang W. Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant Klebsiella pneumoniae in China: a review over the last 10 years. J Glob Antimicrob Resist. 2020;23:174–180. doi:10.1016/j.jgar.2020.09.004
   PubMed Web of Science ®Google Scholar
• Tan D, Zhang Y, Cheng M, et al. Characterization of Klebsiella pneumoniae ST11 Isolates and Their Interactions with Lytic Phages. Viruses. 2019;11(11):1080. doi:10.3390/v11111080
   PubMed Web of Science ®Google Scholar
• Yu X, Zhang W, Zhao Z, et al. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae isolates with focus on antimicrobial resistance. BMC Genomics. 2019;20(1):822. doi:10.1186/s12864-019-6225-9
   PubMed Web of Science ®Google Scholar
• Zeng L, Deng Q, Zeng T, Liu Y, Zhang J, Cao X. Prevalence of Carbapenem-Resistant Klebsiella pneumoniae Infection in Southern China: clinical Characteristics, Antimicrobial Resistance, Virulence, and Geographic Distribution. Microb Drug Resist. 2020;26(5):483–491. doi:10.1089/mdr.2018.0401
   PubMed Web of Science ®Google Scholar
• Patil S, Chen X, Wen F. Exploring the phenotype and genotype of multi-drug resistant Klebsiella pneumoniae harbouring blaCTX-M group extended-spectrum beta-lactamases recovered from paediatric clinical cases in Shenzhen, China. Ann Clin Microbiol Antimicrob. 2019;18(1):32. doi:10.1186/s12941-019-0331-z
   PubMed Web of Science ®Google Scholar
• Patil S, Chen H, Guo C, et al. Emergence of Klebsiella pneumoniae ST307 Co-Producing CTX-M with SHV and KPC from Paediatric Patients at Shenzhen Children’s Hospital, China. Infect Drug Resist. 2021;14:3581–3588. doi:10.2147/IDR.S324018
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang X, Wang J, et al. Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: data From a Longitudinal Large-scale CRE Study in China (2012-2016). Clin Infect Dis. 2018;67(suppl_2):S196–S205. doi:10.1093/cid/ciy660
   PubMedGoogle Scholar
• Zhang Y, Jin L, Ouyang P, et al. Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis. J Antimicrob Chemother. 2020;75(2):327–336. doi:10.1093/jac/dkz446
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang X, Cai L, Zong Z. Enhanced survival of ST-11 carbapenem-resistant Klebsiella pneumoniae in the intensive care unit. Infect Control Hosp Epidemiol. 2020;41(6):740–742. doi:10.1017/ice.2020.68
   PubMed Web of Science ®Google Scholar
• Su S, Li C, Zhao Y, et al. Outbreak of KPC-2-Producing Klebsiella pneumoniae ST76 Isolates in an Intensive Care Unit and Neurosurgery Unit. Microb Drug Resist. 2020;26(9):1009–1018. doi:10.1089/mdr.2019.0363
   PubMed Web of Science ®Google Scholar